Browse All Resources

Investigators often request language to describe the CCTS and/or a specific service or resource for inclusion in a grant application. The CCTS Overview and Service Core Description provides the necessary information for most applications.

UIC provides bloodborne pathogen training through the online Exposure Control Plan provided by the Environmental Health and Safety Office.

The Request for Use of University Hospitals and Clinic Services form is required for investigators who wish to use hospital or clinic technical services as part of a clinical trial.

The Medical Visualization Center and the Center for Magnetic Resonance Research is a campus-wide facility that provides state-of-the-art capabilities in magnetic resonance technology and a core faculty of researchers focusing on MR technology for visualization.

ORS assists faculty and staff in proposal development, review and endorsement of proposals, submission of electronic proposals, negotiation and execution of contracts, reporting, receipt and processing of the Notice of Awards (NOA), interpretation of sponsor guidelines, and ensuring compliance with both agency and University policies.

The Office for the Protection of Research Subjects (OPRS) provides administrative support for the review and approval of research protocols (experiments) involving humans and human embryonic stem cells (hES).

The Centers for Disease Control and Prevention provide information on human participant protection in clinical investigations involving human subjects and the use of drugs, biologics or devices.

The Trial Innovation Network (TIN) is a collaborative national network that focuses on operational innovation, excellence and collaboration and will leverage the expertise and resources of the CTSA Program.

Learn more about the Trial Innovation Network

Contact UIC's TIN Liaisons 

 

Certain types of clinical trials are required by law to be registered when they begin, and the information updated throughout the study.

FDA regulations and guidance documents are accessible from this site as well as international GCP guidance documents on which FDA has collaborated and that have been adopted as official FDA guidance.

Pages